Ask AI

Precision Pathways in RCC: Translating Immunotherapy and Targeted Therapy Advances Into Personalized Patient Care

Integrate the latest evidence from pivotal and emerging trials of immunotherapy and targeted agents into care for patients with RCC to optimize outcomes through an expert-authored ClinicalThought commentary and certified on-demand webcast with accompanying downloadable slides.

Share

Program Content

Events

Activities

Frontline Landscape of RCC
The Frontline Landscape of RCC and Clear Cell RCC: Foundations
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 28, 2026

Neoadjuvant and Adjuvant Horizons
Neoadjuvant and Adjuvant Horizons: Personalizing Therapy in Early-Stage Disease
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 28, 2026

Refractory Renal Cell Carcinoma
Refractory Renal Cell Carcinoma: Multidisciplinary Insights and Future Directions
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 28, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education.

Supporters

This educational activity is supported by medical education grants from AVEO Pharmaceuticals, Inc., Bristol Myers Squibb, Eisai Inc., Exelixis, Inc., and Merck Sharp & Dohme LLC.

AVEO Pharmaceuticals, Inc.

Bristol Myers Squibb

Eisai Inc.

Exelixis, Inc.

Merck Sharp & Dohme, LLC